• Health & Medicine

First ‘targeted’ bowel cancer treatment combo approved for NHS use in England 

The first chemotherapy-free drug combination for people with a rare type of bowel cancer has been approved for NHS use in England.   The first chemotherapy-free drug combination for people with a rare type of bowel cancer has been approved for NHS use in England.  

20 November 2020

• For Supporters

The thrills and skills of becoming an entrepreneur

We speak to five researchers who took the plunge and developed their ideas into brand-new businesses. We speak to five researchers who took the plunge and developed their ideas into brand-new businesses.

19 November 2020

• Health & Medicine

Chemotherapy free treatment for leukaemia given the green light for NHS in England

A new combination of targeted treatments will now be available for some adults with leukaemia on the NHS in England. A new combination of targeted treatments will now be available for some adults with leukaemia on the NHS in England.

13 November 2020

• Health & Medicine

Four new cancer drugs approved on NHS in Scotland

The Scottish Medicines Consortium (SMC) has approved 4 new cancer drugs for use on the NHS in Scotland to treat some lung, breast and prostate cancers. The Scottish Medicines Consortium (SMC) has approved 4 new cancer drugs for use on the NHS in Scotland to treat some lung, breast and prostate cancers.

13 November 2020

• Charity News

Charity CEOs warn of irreparable damage to UK research

A crisis in charity research funding caused by the COVID-19 pandemic threatens to delay the pace of life saving discoveries. A crisis in charity research funding caused by the COVID-19 pandemic threatens to delay the pace of life saving discoveries.

13 November 2020

• Science & Technology

The long road to targeting the holy grail of the immune response

A team of our scientists at University College London have developed a potential new immunotherapy drug and caused another paradigm shift in our understanding of how cancer immunotherapy works. A team of our scientists at University College London have developed a potential new immunotherapy drug and caused another paradigm shift in our understanding of how cancer immunotherapy works.

9 November 2020

• Health & Medicine
• Policy & Insight

Learning the lessons of COVID-19: Protecting cancer services and research through the pandemic

We're calling on UK governments to stand by their commitments to improving cancer survival and make sure everyone can receive the care they deserve. We're calling on UK governments to stand by their commitments to improving cancer survival and make sure everyone can receive the care they deserve.

9 November 2020

• Health & Medicine

Scientists develop next-generation immunotherapy now entering early phase clinical trials

Cancer Research UK scientists have invented a new experimental drug that aims to harness the full power of the body’s own immune system. Cancer Research UK scientists have invented a new experimental drug that aims to harness the full power of the body’s own immune system.

9 November 2020

• Charity News

Cancer Research UK shops in England close during lockdown

Cancer Research UK’s 470 charity shops in England have closed for one month from 5 November, following the announcement of a national lockdown. Cancer Research UK’s 470 charity shops in England have closed for one month from 5 November, following the announcement of a national lockdown.

6 November 2020

• Health & Medicine

What's happened to cancer clinical trials during the COVID-19 pandemic?

As coronavirus cases continue to rise in the UK, we look at how cancer clinical trials have been affected by the pandemic. As coronavirus cases continue to rise in the UK, we look at how cancer clinical trials have been affected by the pandemic.

4 November 2020

• For Supporters

Professor Rebecca Fitzgerald: “We're on the cusp of being able to make more precise cancer diagnoses”

The indefatigable inventor of the Cytosponge-TFF3 detection test, Professor Rebecca Fitzgerald, shares the story of its creation. The indefatigable inventor of the Cytosponge-TFF3 detection test, Professor Rebecca Fitzgerald, shares the story of its creation.

4 November 2020

• For Researchers

Researcher voices: The thrills and skills of becoming an entrepreneur

Five researchers tell us about how they took the plunge and started their own companies. Five researchers tell us about how they took the plunge and started their own companies.

2 November 2020